Rani Therapeutics Holdings, Inc.RANI财报
Nasdaq
RANI Q3 2025 Key Financial Metrics
营收
$0
毛利润
N/A
营业利润
$-7.3M
净利润
$-5.4M
毛利率
N/A
营业利润率
N/A
净利率
N/A
同比增长
N/A
EPS
$-0.12
Rani Therapeutics Holdings, Inc. Q3 2025 财务摘要
Rani Therapeutics Holdings, Inc. reported revenue of $0 for Q3 2025, with a net profit of $-5.4M (up 20.2% YoY) (N/A margin). Cost of goods sold was N/A.
核心财务指标
| 总营收 | $0 |
|---|---|
| 净利润 | $-5.4M |
| 毛利率 | N/A |
| 营业利润率 | N/A |
| 报告期 | Q3 2025 |
Rani Therapeutics Holdings, Inc. 季度营收与净利润历史
Rani Therapeutics Holdings, Inc. quarterly results over the last 6 reported quarters, including revenue, net profit and year-over-year growth.
| 季度 | 营收 | 营收同比 | 净利润 | 净利率 |
|---|---|---|---|---|
| Q3 2025 | $0 | — | $-5.4M | N/A |
| Q2 2025 | $0 | — | $-6.7M | N/A |
| Q1 2025 | $172.0K | — | $-7.3M | -4223.3% |
| Q3 2024 | $0 | — | $-6.8M | N/A |
| Q2 2024 | $0 | — | $-6.8M | N/A |
| Q1 2024 | $0 | — | $-7.5M | N/A |
利润表
| Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|
| 营收 | $0 | $0 | $0 | $172000 | $0 | $0 |
| 同比增长 | N/A | N/A | N/A | N/A | N/A | N/A |
资产负债表
| Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|
| 总资产 | $53.5M | $43.7M | $43.5M | $24.1M | $16.9M | $10.1M |
| 总负债 | $39.0M | $38.2M | $37.8M | $29.5M | $26.1M | $22.1M |
| 股东权益 | $7.4M | $2.8M | $3.1M | $-3.1M | $-5.6M | $-7.9M |
现金流量表
| Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|
| 经营性现金流 | $-9.4M | $-9.0M | $-8.4M | $-8.1M | $-5.8M | $-5.1M |